CompaniesIntica Biomedical

Intica Biomedical

defunct
About

Defunct Company

Areas of Focus

Categories

BankruptBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (7)
View all

Total Trials

7

As Lead Sponsor

6

As Collaborator

1

Total Enrollment

449

By Phase

NA: 6PHASE2: 1

By Status

COMPLETED: 4RECRUITING: 2TERMINATED: 1
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
NCT04182451
NCT05193929
NCT05304481
Hover over trial bars to see details

Recent Trials

NCT06715696Lead Sponsor
"The Hemostatic Effectiveness of HANBIO Gauze During Non-emergent Gynecology Surgery."
NACompleted
40 participants
Started: Dec 15, 2024 · Completed: Mar 31, 2025
NCT05036525Lead Sponsor
Evaluation of the Efficacy and Safety of a Hyaluronic Acid Gel in Adhesion Prevention After Open Thyroidectomy.
NACompleted
100 participants
Started: Jun 17, 2022 · Completed: Apr 17, 2023
NCT05304481Lead Sponsor
Efficacy and Safety of Activated T Lymphocytes (ATL) in Hepatocellular Carcinoma
PHASE2Recruiting
95 participants
Started: May 14, 2022 · Completed: Jun 30, 2027
NCT05193929Lead Sponsor
A Clinical Investigation Evaluating Wound Closure with OptiPulse™ Versus SOC in the Treatment of Non-Healing DFU's
NARecruiting
100 participants
Started: Dec 15, 2021 · Completed: Dec 1, 2025
NCT05263102Lead Sponsor
Evaluation of the Efficacy and Safety of A High Molecular Weight, Natural Hyaluronic Acid Vaginal Gel in Women With Genitourinary Syndrome of Menopause
NACompleted
80 participants
Started: Mar 1, 2020 · Completed: Aug 13, 2022
View all 7 trials →
Funding History (2)
D/A
Jan 31, 2013
Filing
D
Mar 15, 2012
Filing